Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant
Abstract Most antibody-based therapeutics approved for SARS-CoV-2 treatment have shown greatly reduced neutralization activity against emerging Omicron variants. To target recent Omicron variants, we developed XBB-specific antibody-like therapeutics by screening a yeast surface-displayed single-doma...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Viruses |
| Online Access: | https://doi.org/10.1038/s44298-025-00101-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|